GLENMARK
GLENMARK PHARMACEUTICALSHealthcare
LTP
2,279.1
CHG · %
+9.1 (+0.40%)
VOL · TODAY
4.38L
PREV CLOSE
2,270
Today's range2,256 · 2,289
2,279.1
52-week range1,792.6 · 2,474
2,279.1
Loading candles…
Glenmark Pharmaceuticals Ltd is a global research-driven pharmaceutical company headquartered in India, operating in the pharmaceutical industry. The company is involved in generics, specialty products, and innovative medicines, with business segments including generics, specialty, and over-the-counter (OTC) products. Glenmark has a presence in over 80 countries, including India, North America, Europe, and emerging markets. It operates 11 manufacturing facilities and four research and development centers. The company's core therapeutic areas are Dermatology, Respiratory, and Oncology. Glenmark's product portfolio includes branded generics, specialty products, and innovative medicines focused on these therapeutic segments. No information on founding details, key management, subsidiaries, or stock exchange listings is provided.
This page is a live market overview for GLENMARK PHARMACEUTICALS (GLENMARK) on the NSE. As a listed security, GLENMARK PHARMACEUTICALS is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for GLENMARK before placing trades on tick2trade.
As of the latest feed, GLENMARK last traded at ₹2,279.1 on NSE, up ₹9.1 (0.40%) from the previous close of ₹2,270. Today's session range is ₹2,256 – ₹2,289, against a 52-week band of ₹1,792.6 – ₹2,474. Traded volume today stands at 4.38L shares.
The overview consolidates an interactive price chart with multiple time ranges, a near-the-money option chain snapshot, recent market headlines, upcoming corporate events for GLENMARK in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether GLENMARK is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for GLENMARK PHARMACEUTICALS before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in GLENMARK. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated GLENMARK option chain page linked from this overview.
// similar in healthcare314 total